CMV in Moderately Active Colitis: Much Ado About Nothing?

Moss, Alan C.
April 2010
Digestive Diseases & Sciences;Apr2010, Vol. 55 Issue 4, p880
Academic Journal
In this article the author discusses the prevalence of Cytomegalovirus (CMV) infection in patients with inflammatory bowel disease (IBD), and comments on the interaction between the two conditions. He mentions a paper by Kim et al. in the current issue which addresses the prevalence of CMV in patients with moderate and mild colitis, and their outcomes upon treatment with antivirals and steroids.


Related Articles

  • Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Nakase, Hiroshi; Yoshino, Takuya; Honzawa, Yusuke; Chiba, Tsutomu // Digestive Diseases & Sciences;May2010, Vol. 55 Issue 5, p1498 

    The article discusses the study on the incidence of cytomegalovirus (CMV) infection in patients with ulcerative colitis (UC). It notes that the 12 out of the 120 patients with UC and none of the 20 patients with Crohn's disease (CD) had CMV infections, although the number of patients with CD in...

  • Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. Kuwabara, Akifumi; Okamoto, Haruhiko; Suda, Takeyasu; Ajioka, Yoichi; Hatakeyama, Katsuyoshi // Journal of Gastroenterology;Oct2007, Vol. 42 Issue 10, p823 

    In this study we aimed to identify clinically relevant patterns of cytomegalovirus (CMV) infection in inflammatory bowel disease. Twenty-two patients with severe ulcerative colitis (UC), 12 with moderate UC, and 16 with Crohn's disease were studied retrospectively. We confirmed CMV infection...

  • Fenotipo e historia natural de la enfermedad inflamatoria intestinal en un centro de referencia en Medell�n-Colombia. Ba�os, Fabi�n Juliao; V�lez, Mario Hern�n Ruiz; Arango, Jos� Fernando Fl�rez; G�mez, Jorge Hernando Donado; Zuluaga, Juan Ignacio Mar�n; Arango, Claudia Monsalve; G�mez, Carlos Andr�s Jim�nez; Zapata, Yineth Agudelo; Velayos, Fernando S. // Revista Colombiana de Gastroenterolog�a;Jul2012, Vol. 25 Issue 3, p240 

    Worldwide the frequencies of inflammatory bowel disease, ulcerative colitis and Crohn�s disease have all increased. In our own environment it has become necessary to establish the epidemiology of these entities and to determine their clinical and endoscopic behavior. Methodology: This is a...

  • In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Bridger, S.; Lee, J.C.W.; Bjarnason, I.; Lennard Jones, J.E.; Macpherson, A.J. // Gut;Jul2002, Vol. 51 Issue 1, p21 

    Background and aims: Smoking tobacco has opposite effects on the different forms of inflammatory bowel disease (IBD). It predisposes to the development of Crohn's disease (CD) yet is associated with a reduced incidence of ulcerative colitis (UC). We have studied sib pairs discordant for both...

  • Inflammatory bowel disease. O'Malley, John; Spinks, Julian // Pulse;5/25/2011, Vol. 71 Issue 19, p16 

    The article presents questions and answers related to irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), including the diagnostic process of IBD, what drug therapy to treat Crohn's disease, and the risk of cancer with ulcerative colitis.

  • Body composition in patients with inflammatory bowel disease: a population-based study. Jahnsen, Jørgen; Falch, Jan Arvid; Mowinckel, Petter; Aadland, Erling // American Journal of Gastroenterology;Jul2003, Vol. 98 Issue 7, p1556 

    : ObjectivesWeight loss and nutritional depletion are common features of inflammatory bowel disease. Our aim was to assess body composition in patients with Crohn’s disease (CD) and ulcerative colitis (UC) and to evaluate possible differences between the patient groups and healthy...

  • Inflammatory bowel diseases.  // Mayo Clinic Health Letter;Oct2001, Vol. 19 Issue 10, p1 

    Discusses inflammatory bowel diseases. Etiology; Difference between Crohn's disease and ulcerative colitis; Signs and symptoms; Diagnostic techniques; Cancer risks; Treatment strategies. INSET: Colon cancer risks..

  • Kallikrein-kinin system activation in Crohn’s disease: differences in intestinal and systemic markers Devani, Massimo; Cugno, Massimo; Vecchi, Maurizio; Ferrero, Stefano; Di Berardino, Federica; Avesani, Ettore Contessini; de Franchis, Roberto; Colman, Robert W. // American Journal of Gastroenterology;Aug2002, Vol. 97 Issue 8, p2026 

    OBJECTIVES:Observations in experimental models and in human ulcerative colitis suggest that activation of the kallikrein-kinin system plays a role in the pathogenesis of inflammatory bowel disease. The aim of this study was to assess activation of the plasma and tissue kallikrein-kinin system in...

  • Unlocking the secrets of IBD. SerVaas, Cory // Saturday Evening Post;Jan/Feb94, Vol. 266 Issue 1, p42 

    Presents interviews with seven inflammatory disease specialists. Case for cyclosporine; Tracing genetic links; Choosing the right treatment; Longevity, pregnancy and new drugs; Alternatives to lleostomy; Iron and IBD; What causes IBD? INSETS: Now in remission, by Patrick Perry.;A cse of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics